The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Analysis: The peptide problem: Hype is outrunning the evidence McMaster News Peptides are surging in popularity. There's little evidence that they work.